Simpa S. Salami, MD, MPH, is a fellowship-trained, board-certified Urologic Oncologist and Associate Professor of Urology at the University of Michigan. Dr. Salami is a translational surgeon-scientist whose research interests are in early detection and staging of prostate and kidney cancer. He has served on several national guideline committees, such as the AUA Prostate Cancer Early Detection Guidelines, the NCCN Prostate Cancer Early Detection Guidelines, and the Society of Nuclear Medicine and Imaging PSMA PET Appropriate Use Criteria Working Group. His research is supported by multiple sources and includes funding from the Department of Defense, National Cancer Institute, and the Prostate Cancer Foundation.